A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 9, Issue 372, Pages eaag2611
Publisher
American Association for the Advancement of Science (AAAS)
Online
2017-01-12
DOI
10.1126/scitranslmed.aag2611
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combining antibody–drug conjugates and immune-mediated cancer therapy: What to expect?
- (2016) Hans-Peter Gerber et al. BIOCHEMICAL PHARMACOLOGY
- Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions
- (2015) M. Damelin et al. CLINICAL CANCER RESEARCH
- 28LBA A phase 1 study of PF-06647020, an antibody-drug conjugate targeting PTK7, in patients with advanced solid tumors
- (2015) A.W. Tolcher et al. EUROPEAN JOURNAL OF CANCER
- The PTK7 and ROR2 Protein Receptors Interact in the Vertebrate WNT/Planar Cell Polarity (PCP) Pathway
- (2015) Sébastien Martinez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
- (2015) Devon A. Lawson et al. NATURE
- Natural and therapy-induced immunosurveillance in breast cancer
- (2015) Guido Kroemer et al. NATURE MEDICINE
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Evolving Strategies for Target Selection for Antibody-Drug Conjugates
- (2015) Marc Damelin et al. PHARMACEUTICAL RESEARCH
- An FDA oncology analysis of antibody-drug conjugates
- (2015) Haleh Saber et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Trastuzumab emtansine (T-DM1) renders HER2 + breast cancer highly susceptible to CTLA-4/PD-1 blockade
- (2015) Philipp Müller et al. Science Translational Medicine
- Targeting LGR5 + cells with an antibody-drug conjugate for the treatment of colon cancer
- (2015) Melissa R. Junttila et al. Science Translational Medicine
- Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer
- (2015) Anne-Catherine Lhoumeau et al. PLoS One
- Advances in patient-derived tumor xenografts: From target identification to predicting clinical response rates in oncology
- (2014) Edward Rosfjord et al. BIOCHEMICAL PHARMACOLOGY
- A Meta-analysis of Lung Cancer Gene Expression Identifies PTK7 as a Survival Gene in Lung Adenocarcinoma
- (2014) R. Chen et al. CANCER RESEARCH
- Discovery of Cytotoxic Dolastatin 10 Analogues with N-Terminal Modifications
- (2014) Andreas Maderna et al. JOURNAL OF MEDICINAL CHEMISTRY
- PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement
- (2014) Silvia Gärtner et al. PLoS One
- Microtubule-Depolymerizing Agents Used in Antibody-Drug Conjugates Induce Antitumor Immunity by Stimulation of Dendritic Cells
- (2014) P. Muller et al. Cancer Immunology Research
- Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
- (2014) F. S. Hodi et al. Cancer Immunology Research
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma
- (2013) Won-Sik Shin et al. CANCER SCIENCE
- PTK7 modulates Wnt signaling activity via LRP6
- (2013) N. Bin-Nun et al. DEVELOPMENT
- Ptk7 promotes non-canonical Wnt/PCP-mediated morphogenesis and inhibits Wnt/ -catenin-dependent cell fate decisions during vertebrate development
- (2013) M. Hayes et al. DEVELOPMENT
- On translation of antibody drug conjugates efficacy from mouse experimental tumors to the clinic: a PK/PD approach
- (2013) Nahor Haddish-Berhane et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Patient-derived xenografts, the cancer stem cell paradigm and cancer pathobiology in the 21st century
- (2013) Samuel A Williams et al. LABORATORY INVESTIGATION
- Maturing antibody–drug conjugate pipeline hits 30
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- Antibody-Drug Conjugates in Cancer Therapy
- (2012) Eric L. Sievers et al. Annual Review of Medicine
- The many roles of PTK7: A versatile regulator of cell–cell communication
- (2012) Hanna Peradziryi et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Antigen Shedding May Improve Efficiencies for Delivery of Antibody-Based Anticancer Agents in Solid Tumors
- (2012) Y. Pak et al. CANCER RESEARCH
- Wnt5a inhibits the CpG oligodeoxynucleotide-triggered activation of human plasmacytoid dendritic cells
- (2012) K. Hack et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Insights into Ectodomain Shedding and Processing of Protein-tyrosine Pseudokinase 7 (PTK7)
- (2012) Vladislav S. Golubkov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms
- (2012) S. Demoulin et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Long-term Tumor Regression Induced by an Antibody-Drug Conjugate That Targets 5T4, an Oncofetal Antigen Expressed on Tumor-Initiating Cells
- (2012) P. Sapra et al. MOLECULAR CANCER THERAPEUTICS
- The landscape of cancer genes and mutational processes in breast cancer
- (2012) Philip J. Stephens et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome
- (2010) T. Prebet et al. BLOOD
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Silencing of PTK7 in Colon Cancer Cells: Caspase-10-Dependent Apoptosis via Mitochondrial Pathway
- (2010) Ling Meng et al. PLoS One
- Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
- (2009) Bin-Bing S. Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesis
- (2008) Won-Sik Shin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Genomic Changes and Gene Expression Profiles Reveal That Established Glioma Cell Lines Are Poorly Representative of Primary Human Gliomas
- (2008) A. Li et al. MOLECULAR CANCER RESEARCH
- Mapping and quantifying mammalian transcriptomes by RNA-Seq
- (2008) Ali Mortazavi et al. NATURE METHODS
- Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
- (2008) Anne-Pierre Morel et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started